Phosphodiesterase Inhibition to Sensitize Non-Small-Cell Lung Cancer to Pemetrexed: A Double-Edged Strategy
Anna V. Ivanina Foureau(Levine Cancer Institute), Kathryn F. Mileham(Levine Cancer Institute)
Cited by 2
Related Papers
Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
|JAMA Oncology|2018|689
<i>NRG1</i> fusions in solid tumors.
|Journal of Clinical Oncology|2023|7